| Long-term toxicity of cisplatin in germ-cell tumor survivors M Chovanec, MA Zaid, N Hanna, N El-Kouri, LH Einhorn, C Albany Annals of Oncology 28 (11), 2670-2679, 2017 | 182 | 2017 |
| Biomarker panel for chronic graft-versus-host disease J Yu, BE Storer, K Kushekhar, M Abu Zaid, Q Zhang, PR Gafken, Y Ogata, ... Journal of Clinical Oncology 34 (22), 2583-2590, 2016 | 145 | 2016 |
| Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study SL Kerns, C Fung, PO Monahan, S Ardeshir-Rouhani-Fard, MI Abu Zaid, ... Journal of Clinical Oncology 36 (15), 1505-1512, 2018 | 116 | 2018 |
| Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy C Fung, HD Sesso, AM Williams, SL Kerns, P Monahan, M Abu Zaid, ... Journal of Clinical Oncology 35 (11), 1211-1222, 2017 | 105 | 2017 |
| Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT M Abu Zaid, J Wu, C Wu, BR Logan, J Yu, C Cutler, JH Antin, S Paczesny, ... Blood, The Journal of the American Society of Hematology 129 (2), 162-170, 2017 | 92 | 2017 |
| Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring J Zhu, D Djukovic, L Deng, H Gu, F Himmati, M Abu Zaid, EG Chiorean, ... Analytical and bioanalytical chemistry 407, 7857-7863, 2015 | 65 | 2015 |
| Dipeptidyl peptidase 4 inhibition for prophylaxis of acute graft-versus-host disease SS Farag, M Abu Zaid, JE Schwartz, TC Thakrar, AJ Blakley, R Abonour, ... New England Journal of Medicine 384 (1), 11-19, 2021 | 50 | 2021 |
| Exploring metabolic profile differences between colorectal polyp patients and controls using seemingly unrelated regression C Chen, L Deng, S Wei, GA Nagana Gowda, H Gu, EG Chiorean, ... Journal of Proteome Research 14 (6), 2492-2499, 2015 | 37 | 2015 |
| High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation SS Farag, R Nelson, MS Cairo, HA O’Leary, S Zhang, C Huntley, ... Oncotarget 8 (66), 110350, 2017 | 36 | 2017 |
| Predicting cardiovascular disease among testicular cancer survivors after modern cisplatin-based chemotherapy: application of the Framingham Risk Score DR Feldman, S Ardeshir-Rouhani-Fard, P Monahan, HD Sesso, C Fung, ... Clinical genitourinary cancer 16 (4), e761-e769, 2018 | 34 | 2018 |
| Immunotherapeutic concepts to target acute myeloid leukemia: focusing on the role of monoclonal antibodies, hypomethylating agents and the leukemic microenvironment OB Gbolahan, AM Zeidan, M Stahl, M Abu Zaid, S Farag, S Paczesny, ... International Journal of Molecular Sciences 18 (8), 1660, 2017 | 32 | 2017 |
| Clinical and genetic risk factors for adverse metabolic outcomes in North American testicular cancer survivors MA Zaid, WG Gathirua-Mwangi, C Fung, PO Monahan, O El-Charif, ... Journal of the National Comprehensive Cancer Network 16 (3), 257-265, 2018 | 31 | 2018 |
| Predictors of cardiopulmonary arrest outcome in a comprehensive cancer center intensive care unit FA Khasawneh, MT Kamel, MI Abu-Zaid Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 21, 1-5, 2013 | 27 | 2013 |
| Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma C Dong, A Cesarano, G Bombaci, JL Reiter, CY Yu, Y Wang, Z Jiang, ... Oncogene 40 (42), 6130-6138, 2021 | 22 | 2021 |
| Adverse health outcomes in relationship to hypogonadism after chemotherapy: a multicenter study of testicular cancer survivors MA Zaid, PC Dinh, PO Monahan, C Fung, O El-Charif, DR Feldman, ... Journal of the National Comprehensive Cancer Network 17 (5), 459-468, 2019 | 20 | 2019 |
| Altered metabolite levels and correlations in patients with colorectal cancer and polyps detected using seemingly unrelated regression analysis C Chen, GA Nagana Gowda, J Zhu, L Deng, H Gu, EG Chiorean, ... Metabolomics 13, 1-10, 2017 | 19 | 2017 |
| Solid and hematologic neoplasms after testicular cancer: a US population-based study of 24 900 survivors MT Milano, PC Dinh, H Yang, MA Zaid, SD Fossa, DR Feldman, ... JNCI Cancer spectrum 4 (3), pkaa017, 2020 | 18 | 2020 |
| Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: Report of two consecutive clinical trials H Sayar, LD Cripe, AN Saliba, MA Zaid, H Konig, HS Boswell Leukemia Research 77, 30-33, 2019 | 18 | 2019 |
| Ibrutinib for first-line treatment of chronic graft-versus-host disease: results from the randomized phase III iNTEGRATE study DB Miklos, M Abu Zaid, JP Cooney, JC Albring, M Flowers, AP Skarbnik, ... Journal of Clinical Oncology 41 (10), 1876-1887, 2023 | 16 | 2023 |
| Phase 1 study of axatilimab (SNDX-6352), a CSF-1R humanized antibody, for chronic graft-versus-host disease after 2 or more lines of systemic treatment M Arora, M Jagasia, A Di Stasi, ML Meyers, C Quaranto, A Schmitt, ... Blood 136, 1-2, 2020 | 16 | 2020 |
